AMW GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable subcutaneous implants for the treatment of various hormone responding tumors, chronic pain and psychiatric diseases. Its products for licensing include Goserelin implant, Leuprorelin implant, Buprenorphin patch and Rivastigmin patch. AMW offers development partnerships with open and transparent collaboration with licensees for exclusive products. The company develops patented technologies for the active control of drug releasing pharmaceuticals. AMW is headquartered in Warngau, Germany.

AMW GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AMW GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AMW Receives USD29.6 Million of Financing 11
AMW Raises USD6.4 Million in Venture Financing 12
AMW Raises USD9 Million in Venture Financing 13
AMW Raises Funds in Venture Financing 15
AMW Raises Funds in Third Round of Financing 16
Private Equity 17
AMW to Sell Shares to Hybio Pharma and YF Capital Led Consortium 17
AMW GmbH - Key Competitors 19
AMW GmbH - Key Employees 20
AMW GmbH - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Government and Public Interest 22
Dec 21, 2017: Investment Plan for Europe: EIB grants financing to pharmaceutical company AMW 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


AMW GmbH, Pharmaceuticals & Healthcare, Key Facts 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AMW Receives USD29.6 Million of Financing 11
AMW Raises USD6.4 Million in Venture Financing 12
AMW Raises USD9 Million in Venture Financing 13
AMW Raises Funds in Venture Financing 15
AMW Raises Funds in Third Round of Financing 16
AMW to Sell Shares to Hybio Pharma and YF Capital Led Consortium 17
AMW GmbH, Key Competitors 19
AMW GmbH, Key Employees 20

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

AMW GmbH - Pharmaceuticals and Healthcare - Deals and Alliances Profile

AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops

USD 250 View Report

ExamWorks Group Inc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

ExamWorks Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe ExamWorks Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Gilupi GmbH - Product Pipeline Analysis, 2019 Update

Gilupi GmbH (Gilupi) is a medical device company that develops and manufactures devices for the in vivo isolation of rare cells from the circulation. The company develops medical detector that

USD 750 View Report

Oettinger Brauerei GmbH - Strategy, SWOT and Corporate Finance Report

Oettinger Brauerei GmbH - Strategy, SWOT and Corporate Finance ReportOettinger Brauerei GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available